骨肉瘤
医学
癌症研究
骨髓
微波消融
免疫系统
CD8型
树突状细胞
细胞因子
体内
抗原
免疫疗法
肿瘤抗原
CD11c公司
肿瘤微环境
肿瘤坏死因子α
T细胞
抗原呈递
淋巴结
细胞毒性T细胞
车站3
原发性肿瘤
抗体
免疫学
白细胞介素
抗原提呈细胞
离体
淋巴
肿瘤进展
病理
间质细胞
癌症
作者
Jielong Zhou,Yunhui Zhang,Wenjie Yang,X G Wang,M Li,Yao Mengyu,Wenhan Huang,Xiao Chu,Christopher Schliehe,Manzhi Zhao,Yu Zhang
标识
DOI:10.1136/jitc-2026-014796
摘要
Background Osteosarcoma (OSA) is the most common primary malignant bone tumor in children and adolescents, while no further improvement in survival has been achieved in the past few decades. Microwave ablation (MWA) is an emerging thermal therapy to ablate malignant bone tumors that induces antitumor immunity, while intrinsic mechanisms remain elusive. This study uncovered that MWA treatment promoted interleukin (IL)-18 expression and enhanced the dendritic cell (DC) functions, as well as CD8 + T cells infiltration. Combining IL-18 and anti-programmed cell death protein 1 (PD-1) displayed the additive tumor suppression effects. Methods MWA treated OSA was co-cultured with bone marrow dendritic cells (BMDC) in vitro. RNA-sequencing was performed to analyze the intrinsic mechanism of BMDC after stimulated with MWA treated OSA. Mouse model of primary osteosarcoma of the femur was established for in vivo immune response evaluation, and this model was used to measure the additive tumor eradication of IL-18 and anti-PD-1 combination therapy. Results MWA promoted the activation, antigen uptake and antigen cross-presentation of BMDCs. Mouse models demonstrated that MWA treatment could elevate the proportion of CD8 + T cells and CD11c + DCs both in tumors and draining lymph nodes. The tumor suppression was mediated through the release of IL-18 by MWA-treated OSA and interaction with the IL-18 receptor on DCs, which was reversed after anti-IL-18 antibodies application. Besides, IL-18 cytokine exerted the tumor eradication effect and showed the additive role against OSA when combining anti-PD-1 therapy. Conclusions Our study demonstrated a critical role of IL-18-mediated signaling in the induction of protective immune responses against OSA, which provided a novel mechanism to the explanation of MWA-induced immune activation, and IL-18 cytokine treatment could be considered a feasible, effective therapeutic approach for OSA in the clinic.
科研通智能强力驱动
Strongly Powered by AbleSci AI